Cognizant Investing Cash Flow decreased by 974.7% to -$806.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11414.3%, from -$7.00M to -$806.00M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -52.6% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$721.00M | -$407.00M | -$498.00M | $700.00M | -$471.00M | -$257.00M | -$78.00M | -$215.00M | -$85.00M | -$199.00M | -$238.00M | -$79.00M | -$1.25B | -$79.00M | -$7.00M | -$82.00M | -$66.00M | -$75.00M | -$806.00M |
| QoQ Change | — | +43.6% | -22.4% | +240.6% | -167.3% | +45.4% | +69.6% | -175.6% | +60.5% | -134.1% | -19.6% | +66.8% | <-999% | +93.7% | +91.1% | <-999% | +19.5% | -13.6% | -974.7% |
| YoY Change | — | — | — | — | +34.7% | +36.9% | +84.3% | -130.7% | +82.0% | +22.6% | -10.7% | +7.1% | -528.1% | — | +97.1% | -3.8% | +94.7% | +5.1% | <-999% |